![]() Express Diagnostics Int'l Express Diagnostics Int'l is a company that manufactures and distributes DrugCheck, onsite urine and saliva screening devices for the detection of drugs of abuse. | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | SPARK Neuro SPARK Neuro is a neuroscience company that provides drug development and clinical care solutions. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |
Founding Date | Founding Date 2004 | Founding Date 2014 | Founding Date 2016 | Founding Date 2016 |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Blue Earth, US HQ | Locations San Francisco, US HQ Bozeman, US | Locations Santa Monica, US HQ | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 17 | Employees 2216% increase | Employees 234% decrease | Employees 156% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 75 m | Valuation ($) 53.5 m | Valuation ($) N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 15m (over 9 years ago) | Latest funding round $ 13.5m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 17.8m | Total funding raised $ 13.5m | Total funding raised $ 17m |

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View companySPARK Neuro is a neuroscience company that provides drug development and clinical care solutions.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company